Eric Pauwels Ptc Therapeutics, Inc. (PTCT) insider trading activity

Eric Pauwels is CHIEF EXECUTIVE OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 86,805 shares of PTCT, which is worth approximately $3.63 Million. The most recent transaction as insider was on Jan 08, 2025, when has been sold 2,136 shares (Common Stock) at a price of $44.5 per share, resulting in proceeds of $95,052. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.8K

28.23% 3M change

94.86% 12M change

Total Value Held $3.63 Million

Eric Pauwels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2025	SELL Open market or private sale	$95,052 $44.5 p/Share	2,136 Reduced 2.4%	86,805 Common Stock
Jan 07 2025	SELL Open market or private sale	$72,498 $45.34 p/Share	1,599 Reduced 1.77%	88,941 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	22,000 Added 19.55%	90,540 Common Stock
Apr 17 2024	SELL Open market or private sale	$19,785 $25.14 p/Share	787 Reduced 1.15%	67,694 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	24,300 Added 26.19%	68,481 Common Stock
Jan 30 2024	SELL Open market or private sale	$9,973 $27.25 p/Share	366 Reduced 0.82%	44,181 Common Stock
Jan 09 2024	SELL Open market or private sale	$59,905 $29.01 p/Share	2,065 Reduced 4.43%	44,547 Common Stock
Jan 08 2024	SELL Open market or private sale	$44,936 $28.64 p/Share	1,569 Reduced 3.26%	46,612 Common Stock
May 22 2023	SELL Open market or private sale	$119,411 $59.32 p/Share	2,013 Reduced 4.06%	47,553 Common Stock
May 19 2023	SELL Open market or private sale	$377,520 $58.96 p/Share	6,403 Reduced 11.44%	49,566 Common Stock
May 18 2023	SELL Open market or private sale	$46,263 $58.71 p/Share	788 Reduced 1.39%	55,969 Common Stock
May 17 2023	SELL Open market or private sale	$470,888 $58.51 p/Share	8,048 Reduced 12.42%	56,757 Common Stock
Apr 18 2023	SELL Open market or private sale	$38,093 $52.04 p/Share	732 Reduced 1.12%	64,805 Common Stock
Jan 31 2023	SELL Open market or private sale	$17,111 $45.63 p/Share	375 Reduced 0.57%	65,537 Common Stock
Jan 24 2023	SELL Open market or private sale	$17,034 $47.45 p/Share	359 Reduced 0.54%	65,912 Common Stock
Jan 11 2023	SELL Open market or private sale	$25,329 $44.36 p/Share	571 Reduced 0.85%	66,271 Common Stock
Jan 10 2023	SELL Open market or private sale	$28,462 $42.93 p/Share	663 Reduced 0.98%	66,842 Common Stock
Jan 09 2023	SELL Open market or private sale	$35,744 $41.66 p/Share	858 Reduced 1.26%	67,505 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	18,000 Added 20.84%	68,363 Common Stock
Apr 19 2022	SELL Open market or private sale	$34,951 $42.52 p/Share	822 Reduced 1.62%	49,772 Common Stock
Feb 01 2022	SELL Open market or private sale	$14,680 $40.0 p/Share	367 Reduced 0.72%	50,594 Common Stock
Jan 25 2022	SELL Open market or private sale	$14,112 $39.31 p/Share	359 Reduced 0.7%	50,961 Common Stock
Jan 07 2022	SELL Open market or private sale	$33,358 $38.52 p/Share	866 Reduced 2.45%	34,520 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	16,800 Added 24.66%	51,320 Common Stock
Jan 04 2022	SELL Open market or private sale	$33,175 $41.16 p/Share	806 Reduced 2.23%	35,386 Common Stock

Eric Pauwels

CHIEF EXECUTIVE OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account